Lab-grown Crohn's mini-guts, and is the Unive...

Coming up, we assess the environmental and health impact of conflict in the Middle East. Plus, the gene variants that affect how heavily someone smokes, a medication called ruxolitinib that could help the vitiligo community, and a fascinating new study on interbreeding between Ne ...  Show more

This week, we're exploring polio: a highly infectious viral disease that can attack the nervous system and cause paralysis, mainly in young children. Polio has been pushed to the brink of elimination thanks to global vaccination efforts - but it still persists. In this episode, w ...  Show more

IBS affects over 300 million people globally, yet remains one of the most misunderstood gut conditions. In this episode, we explore the latest science uncovering the real drivers behind IBS - and why your gut microbiome may hold the key to understanding it. Joining us is Dr. Will ...  Show more

We are chatting with James McQuillan one of the Australian Steelers – the Aussie wheelchair rugby team. Not just that but an Australian Steeler who has had an incredible journey from recreational sportsman to national representative in just over 11 months. In this episode James s ...  Show more

You sent in your questions on dementia and now we're tackling them. Professor Tara Spires-Jones, Director of the Centre for Discovery Brain Sciences at the University of Edinburgh, joins James Gallagher to go through the insidehealth@bbc.co.uk mailbag.James also visits mushroom g ...  Show more

Are GLP-1 medications the future of weight loss? On this week’s episode, WHOOP Global Head of Human Performance Principal Scientist, Kristen Holmes, sits down with Dr. Greg Grosicki, WHOOP Senior Research Scientist, to discuss all things GLP-1 and GLP-1 Receptor Agonists (RAs) ...